NASDAQ:CTRECaretrust REIT Stock Price, Forecast & News

Caretrust REIT's stock was trading at $16.99 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, CTRE shares have increased by 11.7% and is now trading at $18.97. View which stocks have been most impacted by Coronavirus.

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Caretrust REIT in the last year. There are currently 3 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Caretrust REIT.

Caretrust REIT is scheduled to release its next quarterly earnings announcement on Tuesday, August 4th 2020. View our earnings forecast for Caretrust REIT.

Caretrust REIT Inc (NASDAQ:CTRE) posted its quarterly earnings results on Thursday, May, 7th. The real estate investment trust reported $0.20 earnings per share for the quarter, missing the consensus estimate of $0.34 by $0.14. The real estate investment trust had revenue of $44.34 million for the quarter, compared to analyst estimates of $43.20 million. Caretrust REIT had a net margin of 29.53% and a return on equity of 5.32%. View Caretrust REIT's earnings history.

Caretrust REIT announced a quarterly dividend on Friday, March 13th. Investors of record on Tuesday, March 31st will be given a dividend of $0.25 per share on Wednesday, April 15th. This represents a $1.00 dividend on an annualized basis and a yield of 5.27%. The ex-dividend date is Monday, March 30th. This is an increase from Caretrust REIT's previous quarterly dividend of $0.23. View Caretrust REIT's dividend history.

Caretrust REIT issued an update on its FY 2020 After-Hours earnings guidance on Thursday, May, 7th. The company provided EPS guidance of 1.32-1.34 for the period.

7 brokerages have issued 1-year price objectives for Caretrust REIT's shares. Their forecasts range from $13.00 to $26.00. On average, they expect Caretrust REIT's share price to reach $21.29 in the next year. This suggests a possible upside of 12.2% from the stock's current price. View analysts' price targets for Caretrust REIT.

News coverage about CTRE stock has been trending negative this week, according to InfoTrie Sentiment Analysis. The research group rates the sentiment of media coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Caretrust REIT earned a media sentiment score of -2.8 on InfoTrie's scale. They also assigned media stories about the real estate investment trust a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the company's share price in the near future. View the latest news aboutCaretrust REIT.

Caretrust REIT saw a decrease in short interest in May. As of May 15th, there was short interest totaling 1,790,000 shares, a decrease of 15.6% from the April 30th total of 2,120,000 shares. Based on an average daily volume of 999,900 shares, the days-to-cover ratio is currently 1.8 days. Approximately 1.9% of the company's stock are short sold. View Caretrust REIT's Current Options Chain.

Some companies that are related to Caretrust REIT include Vornado Realty Trust (VNO), Lamar Advertising (LAMR), Kilroy Realty (KRC), Federal Realty Investment Trust (FRT), Klepierre (KLPEF), Vereit (VER), Healthcare Trust Of America (HTA), CubeSmart (CUBE), Apartment Investment and Management (AIV), National Retail Properties (NNN), Douglas Emmett (DEI), Store Capital (STOR), First Industrial Realty Trust (FR), Kimco Realty (KIM) and CoreSite Realty (COR). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Caretrust REIT investors own include Omega Healthcare Investors (OHI), AGNC Investment (AGNC), Energy Transfer LP Unit (ET), Cisco Systems (CSCO), Medical Properties Trust (MPW), NVIDIA (NVDA), AT&T (T), Verizon Communications (VZ), Enterprise Products Partners (EPD) and Exxon Mobil (XOM).

Caretrust REIT trades on the NASDAQ under the ticker symbol "CTRE."

Caretrust REIT's stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (18.94%), PGGM Investments (9.32%), State Street Corp (4.37%), Invesco Ltd. (3.96%), Bank of New York Mellon Corp (3.19%) and Geode Capital Management LLC (1.50%). View institutional ownership trends for Caretrust REIT.

CTRE stock was sold by a variety of institutional investors in the last quarter, including Centersquare Investment Management LLC, Morgan Stanley, Morgan Stanley, BlackRock Inc., Bank of New York Mellon Corp, Baird Financial Group Inc., Victory Capital Management Inc., and Victory Capital Management Inc.. View insider buying and selling activity for Caretrust REIT.

CTRE stock was acquired by a variety of institutional investors in the last quarter, including PGGM Investments, Cohen & Steers Inc., State Street Corp, Employees Retirement System of Texas, Invesco Ltd., Two Sigma Advisers LP, Nuveen Asset Management LLC, and Geode Capital Management LLC. View insider buying and selling activity for Caretrust REIT.

Shares of CTRE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of CTRE stock can currently be purchased for approximately $18.97.

Caretrust REIT has a market capitalization of $1.82 billion and generates $163.40 million in revenue each year. The real estate investment trust earns $46.36 million in net income (profit) each year or $1.36 on an earnings per share basis. Caretrust REIT employs 57 workers across the globe.

The official website for Caretrust REIT is www.caretrustreit.com.

Caretrust REIT's mailing address is 905 CALLE AMANECER SUITE 300, SAN CLEMENTE CA, 92673. The real estate investment trust can be reached via phone at 949-542-3130 or via email at [email protected]